Ignite Creation Date:
2025-12-24 @ 4:23 PM
Ignite Modification Date:
2026-06-26 @ 4:54 AM
Study NCT ID:
NCT00003166
Status:
COMPLETED
Last Update Posted:
2013-01-11
First Post:
1999-11-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bryostatin and Vincristine in B-Cell Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Recurrent Adult Burkitt Lymphoma | View |
| None | Recurrent Adult Diffuse Large Cell Lymphoma | View |
| None | Recurrent Adult Diffuse Mixed Cell Lymphoma | View |
| None | Recurrent Adult Immunoblastic Large Cell Lymphoma | View |
| None | Recurrent Adult Lymphoblastic Lymphoma | View |
| None | Recurrent Grade 3 Follicular Lymphoma | View |
| None | Recurrent Mantle Cell Lymphoma | View |
| None | Refractory Chronic Lymphocytic Leukemia | View |
| None | Refractory Multiple Myeloma | View |
| None | Stage III Multiple Myeloma | View |
Keywords: